Ecolab (ECL) Expands Product Portfolio With New Technology
Zacks Investment Research | Aug 27, 2019 10:14PM ET
Ecolab Inc. (NYSE:ECL) has recently made an enhancement in its healthcare offerings with the introduction of the next generation of open basin fluid warming systems — the CoreTemp Fluid Management System.
Notably, this new technology marks yet another successful expansion effort with respect to Ecolab’s healthcare offerings. Such enhancements in product portfolio will help the company to drive organic sales.
Details about CoreTemp Fluid Management System
The new technology offers advanced measurement capabilities that will lend support when it comes to the improvement of patient health. It will also help in acknowledging the rising need for process and cost efficiencies in the healthcare industry.
Precise fluid measurement plays an important role when it comes to predictable and controlled patient outcomes. In this regard, CoreTemp system provides innovative technology to automatically and accurately track irrigation fluid volume during the surgery process.
The system aids in lowering the risk of fluid-related complications arising from errors in estimated blood loss calculations. Consequently, this system will help in improving the standard of care for hospitals with data-driven volume tracking and accurate temperature control.
Ecolab’s Product Portfolio at a Glance
Ecolab, a global leader in water, hygiene and energy technologies and services, has major launches underway including the new Smartpowerware wash platform, which is expected to drive institutional improvements. The company also continues to invest significantly in customer-facing and infrastructure technology.
In recent times, the company launched a Life Sciences cleanroom program in North America, developed specially for pharmaceutical manufacturing. The program provides comprehensive cleaning and disinfection for both sterile and non-sterile applications.
Ecolab has been gaining traction in digital technology markets also. The company anticipates huge investments in the coming quarters to enhance digital portfolio.
Market Prospects
Per a report by Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.